Portal de Periódicos da CAPES

Artigo Acesso aberto Produção Nacional Revisado por pares

BIBTEX RIS

SARS-CoV-2 Infection and CMV Dissemination in Transplant Recipients as a Treatment for Chagas Cardiomyopathy: A Case Report

2021; Multidisciplinary Digital Publishing Institute; Volume: 6; Issue: 1 Linguagem: Inglês

10.3390/tropicalmed6010022

2414-6366

Sarah Cristina Gozzi-Silva, Gil Benard, Ricardo Wesley Alberca, Tatiana Mina Yendo, Franciane Mouradian Emidio Teixeira, Luana de Mendonça Oliveira, Danielle Rosa Beserra, Anna Julia Pietrobon, Emily Araujo de Oliveira, Anna Cláudia Calvielli Castelo Branco, Milena Mary de Souza Andrade, Iara Grigoletto Fernandes, Nátalli Zanete Pereira, Yasmim Álefe Leuzzi Ramos, Júlia Cataldo Lima, Bruna Provenci, Sandrigo Mangini, Alberto José da Silva Duarte, Maria Notomi Sato,

Pneumocystis jirovecii pneumonia detection and treatment

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has infected over 90 million people worldwide, therefore it is considered a pandemic. SARS-CoV-2 infection can lead to severe pneumonia, acute respiratory distress syndrome (ARDS), septic shock, and/or organ failure. Individuals receiving a heart transplantation (HT) may be at higher risk of adverse outcomes attributable to COVID-19 due to immunosuppressives, as well as concomitant infections that may also influence the prognoses. Herein, we describe the first report of two cases of HT recipients with concomitant infections by SARS-CoV-2, Trypanosoma cruzi, and cytomegalovirus (CMV) dissemination, from the first day of hospitalization due to COVID-19 in the intensive care unit (ICU) until the death of the patients.